1. Home
  2. ONEW vs IMUX Comparison

ONEW vs IMUX Comparison

Compare ONEW & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneWater Marine Inc.

ONEW

OneWater Marine Inc.

HOLD

Current Price

$11.83

Market Cap

223.8M

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$16.44

Market Cap

209.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONEW
IMUX
Founded
2014
2016
Country
United States
United States
Employees
N/A
66
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
223.8M
209.2M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
ONEW
IMUX
Price
$11.83
$16.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$16.50
$36.00
AVG Volume (30 Days)
105.6K
149.7K
Earning Date
04-30-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
2.77
N/A
Revenue
$1,872,334,000.00
N/A
Revenue This Year
$0.30
N/A
Revenue Next Year
$3.14
N/A
P/E Ratio
$4.34
N/A
Revenue Growth
5.62
N/A
52 Week Low
$8.12
$0.51
52 Week High
$17.53
$17.43

Technical Indicators

Market Signals
Indicator
ONEW
IMUX
Relative Strength Index (RSI) 46.66 55.93
Support Level $11.31 $0.75
Resistance Level $12.12 $17.43
Average True Range (ATR) 0.70 1.05
MACD -0.05 0.05
Stochastic Oscillator 43.17 60.71

Price Performance

Historical Comparison
ONEW
IMUX

About ONEW OneWater Marine Inc.

OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

Share on Social Networks: